1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H1, 2014

Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Transitional (Urothelial) Tract Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Transitional (Urothelial) Tract Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Transitional (Urothelial) Tract Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Metastatic Transitional (Urothelial) Tract Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Metastatic Transitional (Urothelial) Tract Cancer 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Zeltia, S.A. 31
Clinical Trial Overview of Zeltia, S.A. 31
Wissenschaftlicher Service Pharma GmbH 32
Clinical Trial Overview of Wissenschaftlicher Service Pharma GmbH 32
Sanofi 33
Clinical Trial Overview of Sanofi 33
Lukaskrankenhaus GmbH 34
Clinical Trial Overview of Lukaskrankenhaus GmbH 34
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
Astellas Pharma Inc. 36
Clinical Trial Overview of Astellas Pharma Inc. 36
Clinical Trial Overview of Top Institutes / Government 37
National Cancer Institute 37
Clinical Trial Overview of National Cancer Institute 37
Memorial Sloan Kettering Cancer Center 38
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 38
Karolinska University Hospital 39
Clinical Trial Overview of Karolinska University Hospital 39
Kitasato University School of Medicine 40
Clinical Trial Overview of Kitasato University School of Medicine 40
Campania Younger Oncologists Association 41
Clinical Trial Overview of Campania Younger Oncologists Association 41
Kurume University 42
Clinical Trial Overview of Kurume University 42
China Medical University Hospital 43
Clinical Trial Overview of China Medical University Hospital 43
Centre Val d'Aurelle - Paul Lamarque 44
Clinical Trial Overview of Centre Val d'Aurelle - Paul Lamarque 44
The University of Chicago 45
Clinical Trial Overview of The University of Chicago 45
University of Kentucky 46
Clinical Trial Overview of University of Kentucky 46
Five Key Clinical Profiles 47
Appendix 104
Abbreviations 104
Definitions 104
Research Methodology 105
Secondary Research 105
About GlobalData 106
Contact Us 106
Disclaimer 106
Source 107

List of Tables
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 24
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeltia, S.A., 2014* 31
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wissenschaftlicher Service Pharma GmbH, 2014* 32
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 33
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Lukaskrankenhaus GmbH, 2014* 34
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 35
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 36
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 37
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 38
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska University Hospital, 2014* 39
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kitasato University School of Medicine, 2014* 40
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Campania Younger Oncologists Association, 2014* 41
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kurume University, 2014* 42
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by China Medical University Hospital, 2014* 43
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Val d'Aurelle - Paul Lamarque, 2014* 44
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2014* 45
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2014* 46

List of Figures
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 105

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.